1 Drew and Rhondda Wells (Spon. by Lula 0. Lubchenco).
Univ of ~olodical-,=of
Perinatal 13edicine. Denver. Fluorescence quenching as a technique for studying the binding of bilirubin to albumin was reported to the Society in 1977 by Dr. R. Levine. The technique is sensitive enough to measure the two parameters of binding (affinity and capacity) needed to determine the influence of a drug on the binding of bilirubin to albumin. Hence. fluorescence quenching was used to determine the mechanism of action of drugs on bilirubin binding.
The influence and mechanism of action of diazepm (ValiumRoche), furosemide (Lasix -Hoechst-Roussel), sodium diphenylhydantoin (SDPH -Rechelle) and theophylline (Slo-PhyllinDooner) on the, binding of bilirubin to albumin were studied. Valium, a drug previously shown to alter the binding of bilirubin to albumin, exerted its influence winly by affecting the binding affinity, reducing this by 49%. Valium also affected the capacity but to a lesser extent, reducing it by 13%. Lasix also influenced both parameters, reducing the affinity by 5 6 ' and the capacity by 23%. SDPH reduced only the affinity; this being reduced by 567..
Slo-Phyllin had no detrimental influence on the binding of bilirubin to albumin.
Since Valium, Lasix and SDPH all reduce the binding parameters of bilirubin to albumin, they all increase the free bilirubin concentration and hence the clinician is warned as to the possible risks of these drugs in jaundiced newborn infants. Ihe influence of other drugs is currently being investigated. dren. To determine the hemodynamic effects of DB in children we infused DB into ten children with congenital heart disease during the course of routine cardiac catheterization. We infused DB at two doses (2 and 8uglkglmin) for ten minutes each. We measured heart rate (HR), cardiac index (CI), systemic (SAP) and pulmonary arterial (PAP), right atrial (RAP), and pulmonary arterial wedge (PWP) blood pressures before and during infusion of DB. Systemic (SVR) and pulmonary (PVR) vascular resistances and stroke index (51) Vidyasaqar, Dpt. Peds., ALSM, Uni. 1 1 1 . Chicago, I 1 1 closure of patent ductus arterlosus(PDA)with Indomethacin(lnd.)has been previously described.Since failure to close PDA with Ind. has also been noted.We examined plasma concentrations of Ind. in 3 premature infants with patent ductus arteriosus(P~A)following oral administration.Al1 had a clinical3 large POA and echocardiographic evidence of LA/AO ratio of >I.?,.
Ind. was administered through nasogastric tube 0.1 mg/kg in one infant and 0.2 mg/kg in 2 infants q.8.h.Blood was obtained by heel stick at 15.30,mins. and 1,2,4,6,8,and 24 hr. intervals. Plasma levels of Ind. was assayed using a gas liquid chromatography method,following derivitization with triethylanilinium bydrochloride.Daily serum levels of creatinine and plateletcount e r e also foilowed.Results are shown in the Pt. #1 died before the effect of Ind. treatment could be assessed.Pt. #2 had a good response.Pt. #3 had two triaIs(3a.3b) of Ind. therapy.ln this infant LA/AO remained high although there was cl inical improvement following Ind.Maxima1 absorption occurred within 2 hrs. of administration.Marked variation between ~ybjects was pbserved in peak conce tration.Elimjnation half 1 ~f e was cons~derably longer than tlat reported in adults.
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